Ligand-directed retroviral targeting of human breast cancer cells

Xiaoliang Han, Noriyuki Kasahara, Yuet Wai Kan

Research output: Contribution to journalArticle

107 Citations (Scopus)

Abstract

We explored the feasibility of designing retroviral vectors that can target human breast cancer cells with characteristic receptors via ligand- receptor interaction. The ecotropic Moloney murine leukemia virus envelope was modified by insertion of sequences encoding human heregulin. Ecotropic virus, which normally does not infect human cells, when pseudotyped with the modified envelope protein now crosses species to infect human breast cancer cell lines that overexpress HER-2 (human epidermal growth factor receptor; also called ERBB2) and HER-4 (also called ERBB4), while human breast cancer cell lines expressing low levels of these receptors remain resistant to infection. Since about 20% of human breast cancers overexpress HER-2 and some of breast cancer cell lines overexpress both HER-2 and HER-4, cell-specific targeting of retroviral vectors may provide a different approach for in vivo gene therapy of this type of breast cancer.

Original languageEnglish (US)
Pages (from-to)9747-9751
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume92
Issue number21
DOIs
StatePublished - Oct 10 1995
Externally publishedYes

Fingerprint

Breast Neoplasms
Ligands
Cell Line
Neuregulin-1
Moloney murine leukemia virus
Insertional Mutagenesis
Genetic Therapy
Viruses
Infection
Proteins

Keywords

  • ERBB2
  • ERBB4
  • HER-2
  • HER-4
  • heregulin
  • ligand-receptor interaction
  • neu

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Ligand-directed retroviral targeting of human breast cancer cells. / Han, Xiaoliang; Kasahara, Noriyuki; Kan, Yuet Wai.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 92, No. 21, 10.10.1995, p. 9747-9751.

Research output: Contribution to journalArticle

@article{8aedd8aebaed43b0b5bbf464ef96756a,
title = "Ligand-directed retroviral targeting of human breast cancer cells",
abstract = "We explored the feasibility of designing retroviral vectors that can target human breast cancer cells with characteristic receptors via ligand- receptor interaction. The ecotropic Moloney murine leukemia virus envelope was modified by insertion of sequences encoding human heregulin. Ecotropic virus, which normally does not infect human cells, when pseudotyped with the modified envelope protein now crosses species to infect human breast cancer cell lines that overexpress HER-2 (human epidermal growth factor receptor; also called ERBB2) and HER-4 (also called ERBB4), while human breast cancer cell lines expressing low levels of these receptors remain resistant to infection. Since about 20{\%} of human breast cancers overexpress HER-2 and some of breast cancer cell lines overexpress both HER-2 and HER-4, cell-specific targeting of retroviral vectors may provide a different approach for in vivo gene therapy of this type of breast cancer.",
keywords = "ERBB2, ERBB4, HER-2, HER-4, heregulin, ligand-receptor interaction, neu",
author = "Xiaoliang Han and Noriyuki Kasahara and Kan, {Yuet Wai}",
year = "1995",
month = "10",
day = "10",
doi = "10.1073/pnas.92.21.9747",
language = "English (US)",
volume = "92",
pages = "9747--9751",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "21",

}

TY - JOUR

T1 - Ligand-directed retroviral targeting of human breast cancer cells

AU - Han, Xiaoliang

AU - Kasahara, Noriyuki

AU - Kan, Yuet Wai

PY - 1995/10/10

Y1 - 1995/10/10

N2 - We explored the feasibility of designing retroviral vectors that can target human breast cancer cells with characteristic receptors via ligand- receptor interaction. The ecotropic Moloney murine leukemia virus envelope was modified by insertion of sequences encoding human heregulin. Ecotropic virus, which normally does not infect human cells, when pseudotyped with the modified envelope protein now crosses species to infect human breast cancer cell lines that overexpress HER-2 (human epidermal growth factor receptor; also called ERBB2) and HER-4 (also called ERBB4), while human breast cancer cell lines expressing low levels of these receptors remain resistant to infection. Since about 20% of human breast cancers overexpress HER-2 and some of breast cancer cell lines overexpress both HER-2 and HER-4, cell-specific targeting of retroviral vectors may provide a different approach for in vivo gene therapy of this type of breast cancer.

AB - We explored the feasibility of designing retroviral vectors that can target human breast cancer cells with characteristic receptors via ligand- receptor interaction. The ecotropic Moloney murine leukemia virus envelope was modified by insertion of sequences encoding human heregulin. Ecotropic virus, which normally does not infect human cells, when pseudotyped with the modified envelope protein now crosses species to infect human breast cancer cell lines that overexpress HER-2 (human epidermal growth factor receptor; also called ERBB2) and HER-4 (also called ERBB4), while human breast cancer cell lines expressing low levels of these receptors remain resistant to infection. Since about 20% of human breast cancers overexpress HER-2 and some of breast cancer cell lines overexpress both HER-2 and HER-4, cell-specific targeting of retroviral vectors may provide a different approach for in vivo gene therapy of this type of breast cancer.

KW - ERBB2

KW - ERBB4

KW - HER-2

KW - HER-4

KW - heregulin

KW - ligand-receptor interaction

KW - neu

UR - http://www.scopus.com/inward/record.url?scp=0028822547&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028822547&partnerID=8YFLogxK

U2 - 10.1073/pnas.92.21.9747

DO - 10.1073/pnas.92.21.9747

M3 - Article

C2 - 7568210

AN - SCOPUS:0028822547

VL - 92

SP - 9747

EP - 9751

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 21

ER -